BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a partnership with Cell Signaling Technology (“CST”) to advance and validate next-generation protein sequencing and analysis of post-translational modifications (“PTM”) on the Proteus™ single-molecule protein sequencing platform. The partnership will focus on integrating CST’s [...]

Empowering researchers and growing companies with advanced imaging technology and expert support Jena, Germany/ Manchester, United Kingdom | ZEISS Research Microscopy Solutions Bruntwood SciTech, the UK’s leading developer of innovation districts, and ZEISS have announced a strategic partnership designed to support life science research and accelerate innovation across the UK. The partnership brings the advanced [...]

The nonprofit consortium is advancing open-source foundation models and software infrastructure for biology and drug discovery. BERKELEY, Calif. -- OpenFold Consortium, an open science initiative advancing open-source AI tools for biology and drug discovery, announced today that eleven new members have joined the consortium including Absci, Adaptive Biotechnologies, Benchling, Chemical Computing Group, Daiichi Sankyo, Flagship [...]

Funding accelerates Element's open ecosystem of genomic and multiomic technologies including VITARI™, and the upcoming launches of tissue profiling on AVITI24™, and AVITI Dx™ SAN DIEGO, CA – Element Biosciences, Inc. today announced an upsized Series E round of financing, including $175 million from longstanding investor Samsung Electronics, and an undisclosed amount from other investors. [...]

Acquisition Expands 10x Genomics' Capabilities in Proteomics PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the acquisition of Proteintech Genomics, a division within Proteintech Group, a company specializing in developing high-plex proteomic solutions for single cell and spatial applications on 10x [...]

BILLERICA, Mass. -- Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Company’s new Chief Financial Officer, effective June 22. Faessler brings extensive finance leadership experience and expertise in managing complex organizations in the life science tools industry, positioning him to play a [...]

Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing sample preparation time by >90%. Industry-leading Coin Cell DSC temperature range from –80 °C to 600 °C, aiding battery development and QA/QC. MILFORD, Mass. -- Waters Corporation (NYSE: WAT) today announced the [...]

The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights PLEASANTON, Calif. -- PromptBio, a California-based leader in AI for life sciences, announced the launch of the All-New PromptBio Platform, an Agentic AI designed to help scientists accelerate discovery from hypotheses to insights. https://www.youtube.com/watch?v=4lH4RWEHiTQ&source_ve_path=MjM4NTE&embeds_referring_euri=https%3A%2F%2Fwww.tmcnet.com%2F&themeRefresh=1 The platform combines a conversational [...]

SAN JOSE, Calif. -- Complete Genomics today announced the appointment of Edward T. McMullen Jr. to its Board of Directors, further strengthening the company's leadership in global business strategy, international relations and U.S. government affairs. McMullen served as U.S. ambassador to Switzerland and Liechtenstein from 2017 to 2021 and has more than three decades of experience spanning [...]

CellVoyant and Axol Bioscience announce strategic collaboration to advance AI-guided predictive imaging assays for cardiomyocyte manufacturing Collaboration combines CellVoyant AI-powered FateView™ platform with Axol Bioscience induced pluripotent stem cell (iPSC) expertise to enable predictive, non-destructive assessment of cardiomyocyte differentiation processes, enabling the generation of highly pure cell populations at scale. BRISTOL, UK and EDINBURGH, UK [...]